Dr Matthias Staehelin > VISCHER > Basel, Switzerland > Lawyer Profile
VISCHER Offices
AESCHENVORSTADT 4
4010 BASEL
Switzerland
- Firm Profile
- Go to...
Dr Matthias Staehelin
Work Department
Corporate
Position
Partner, Co-head VISCHER Life Sciences Team, primarily involved in the life sciences and IT industries; he regularly advises on the sale and purchase of companies (M&A), financing through investors (private equity and venture capital), licensing and collaboration agreements (including joint ventures), introductions to the stock exchange (IPOs) and restructuring; he also a notary public in Basel-City and Basel-Country.
Career
Partner at VISCHER since 2000. Associate with Gloor Schiess & Partner (1994-1999), Associate with the New York office of Cravath Swaine & Moore (1994).
Languages
English, German, French
Memberships
President of BioValley Basel and a Board member of the BioValley Business Angels Club (BioBAC). Member Swiss and Basel Bar Associations, Swiss Notaries Association and International Bar Association (IBA)
Education
- King’s College, Halifax, Canada (1984-1985)
- University of Basel, Switzerland (lic. iur., 1990; Dr. iur., 1993)
- College of Europe, Bruges, Belgium (Master of Advanced European Studies, 1992/Diplome des Hautes Etudes Europeennes, 1991)
- College: Internationalisierung des Privatrechts Freiburg i.B., Germany (1992/93)
Lawyer Rankings
Switzerland > Healthcare and life sciences
Divided between Zurich and Basel and described by clients as having the ‘best reputation for driving biotech deals in Switzerland’, VISCHER
‘s broad offering spans the full range of corporate issues within the life sciences space, in addition to acting in administrative disputes concerning reimbursement and distribution issues. Stefan Kohler leads the team alongside the ‘outstanding’ Matthias Staehelin. Kohler is a key name for licensing and R&D agreements, in addition to handling both administrative and patent disputes. Staehelin is recommended for his deep knowledge of series financing and fundraising issues, often advising investors and major biotech companies and investors. Christian Wyss is particularly adept at advising on licence terms, and remains a key contact for start-ups, while Vincent Reardon utilises his broad corporate expertise to assist with M&As and IPOs.
Switzerland > Commercial, corporate and M&A
Noted for its ‘highly client-centric approach’, VISCHER is well-positioned to advise clients in innovative industry sectors, such as AI, life sciences, and fintech, on a domestic and cross-border level. The practice is jointly helmed by Jürg Luginbühl, who possesses more than 25 years of experience in managing M&A and private equity deals for a consortium of global clients, Gian-Andrea Caprez, who boasts a strong grounding in technology and life sciences transactions, and Damien Conus, a strong choice for start-ups; he also excels in the equity arena. The former two are based in Zurich and the latter is based in Geneva. Other notable names in the practice include Matthias Staehelin, Robert Bernet and Benedict Christ.